Beam Therapeutics Inc. 10-Q filing
Filed 2025-08-05 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-102393
- Form type
- 10-Q
- CIK
- 0001745999
- Primary document
- https://www.sec.gov/Archives/edgar/data/1745999/000095017025102393/beam-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Beam Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $15.9M | - | - |
| Operating Income | $-239.4M | - | - |
| Net Income | $-211.6M | - | - |
| Eps Basic | -2.23 | - | - |
| Eps Diluted | -2.23 | - | - |
| Cash And Equivalents | $282.1M | - | - |
| Total Assets | $1.4B | - | - |
| Total Liabilities | $344.3M | - | - |
| Shareholders Equity | $1.0B | - | - |
| Operating Cash Flow | $-180.3M | - | - |
| Capital Expenditures | $6.2M | - | - |